Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The bladder cancer clinical trial market research report provides an overview of the bladder cancer clinical trial scenario. The report provides top-line data relating to the clinical trials on bladder cancer. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Bladder Cancer Clinical Trials Market Segmentation by Regions and Countries
The key regions in the bladder cancer clinical trials market are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America.
In a country-wise analysis, as of November 2022, the US has the highest number of bladder cancer clinical trials, followed by China, Spain, the UK, France, Canada, Italy, Japan, Germany, and the Netherlands.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the UK has the highest proportion of bladder cancer to oncology clinical trials. Moreover, out of all the clinical trials conducted in the G7 countries, the majority were in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Turkey has the highest proportion of bladder cancer to oncology clinical trials. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
Bladder Cancer Clinical Trials Analysis by Regions
For more regional insights into the bladder cancer clinical trials market, download a free report sample
Bladder Cancer Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the bladder cancer clinical trials market are institution, company, and the government. Out of them, institution dominates the market.
Bladder Cancer Clinical Trials Market Analysis by Sponsor Types
For more sponsor type insights into the bladder cancer clinical trials market, download a free report sample
Bladder Cancer Clinical Trials Market - Competitive Landscape
The leading sponsors in the bladder cancer clinical trials market are Merck & Co Inc, Bristol-Myers Squibb Co, F. Hoffmann-La Roche Ltd, AstraZeneca Plc, Pfizer Inc, GSK plc, Eli Lilly and Co, Seagen Inc, Astellas Pharma Inc, and Incyte Corp. Out of them, Merck & Co Inc has conducted the highest number of bladder cancer clinical trials.
Bladder Cancer Clinical Trials Market Analysis by Sponsors
To know more about the leading players in the bladder cancer clinical trials market, download a free report sample
Bladder Cancer Clinical Trials Market Report Overview
| Key Regions | North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America |
| Key Countries | The US, China, Spain, The UK, France, Canada, Italy, Japan, Germany, and The Netherlands |
| Key Sponsor Types | Institution, Company, and Government |
| Leading Sponsors | Merck & Co Inc, Bristol-Myers Squibb Co, F. Hoffmann-La Roche Ltd, AstraZeneca Plc, Pfizer Inc, GSK plc, Eli Lilly and Co, Seagen Inc, Astellas Pharma Inc, and Incyte Corp |
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies concerning investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Key Players
Table of Contents
List of Tables
List of Figures
Frequently Asked Questions
The key regions in the bladder cancer clinical trials market are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America.
The key countries in the bladder cancer clinical trials market are the US, China, Spain, the UK, France, Canada, Italy, Japan, Germany, and the Netherlands.
The key sponsor types in the bladder cancer clinical trials market are institution, company, and the government.
The leading sponsors in the bladder cancer clinical trials market are Merck & Co Inc, Bristol-Myers Squibb Co, F. Hoffmann-La Roche Ltd, AstraZeneca Plc, Pfizer Inc, GSK plc, Eli Lilly and Co, Seagen Inc, Astellas Pharma Inc, and Incyte Corp.
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Related reports
View more Oncology reports